Drugs / TPI ASM8
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT00822861 | Apr 2009 → Feb 2010 | asthma | Syntara | Completed | No outcome recorded |
| Phase 2 | NCT00550797 | Jan → Jul 2008 | allergic asthma | Syntara | Completed | No outcome recorded |
| Phase 2 | NCT00402948 | Feb → Nov 2007 | asthma | Syntara | Terminated | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01158898 Comparator | Nov 2010 → Dec 2011 | asthma | Syntara | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TPI ASM8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01158898 ↗ |
| Known as | ASM8 | “No.1 ASM8 (oligonucleotide)” NCT00550797 ↗1“ASM8 as TPI ASM8” NCT00402948 ↗ |
| Modality | Oligonucleotide (other) | “No.1 ASM8 (oligonucleotide)” NCT00550797 ↗ |
| Route | Inhaled | “administered by inhalation” NCT00402948 ↗ |